TODAY, ORGANshortageisthemainlimitingfactortothe widespread applicationoflungtransplant(LT).Only20%of multiorgandonorsaresuitableforlungretrievalduetodifferent causes suchastrauma,pneumonia,andneurogenicedema. Ex vivolungperfusion(EVLP)isanextendedlungassess- ment andconditioningtechniquefordamageddonorlungs.1 However, asanon-transportabledevice,itisperformedonlyat the recipienthospital,thusavoidingpossibledamagethatcould occur duetocoldischemiaduringgrafttransport. The OrganCareSystem(OCS)Lung(Transmedics,And- over, MA)isanewportableEVLPtechnologythatincludesthe benefits ofEVLP,startingitseffectsinthedonorhospital, reducing inthiswaythecoldischemictime(Fig 1).2 According to theINSPIREtrial,theOCSLunghasbeenmostlyusedfor ideal organpreservation,andveryfewcasesofmarginallung reconditioning havebeenreported.3–5 To date,noclinicalcaseshavebeenreportedonclinicaland functional lungperformancewithtissueevaluation.The authors presenttheir first caseofmarginallungreconditioning with theOCSLungsystem.

Normothermic Perfusion of Donor Marginal Lungs with the Organ Care System Lung: Clinical and Morphologic Evaluation

MARULLI, GIUSEPPE;
2016-01-01

Abstract

TODAY, ORGANshortageisthemainlimitingfactortothe widespread applicationoflungtransplant(LT).Only20%of multiorgandonorsaresuitableforlungretrievalduetodifferent causes suchastrauma,pneumonia,andneurogenicedema. Ex vivolungperfusion(EVLP)isanextendedlungassess- ment andconditioningtechniquefordamageddonorlungs.1 However, asanon-transportabledevice,itisperformedonlyat the recipienthospital,thusavoidingpossibledamagethatcould occur duetocoldischemiaduringgrafttransport. The OrganCareSystem(OCS)Lung(Transmedics,And- over, MA)isanewportableEVLPtechnologythatincludesthe benefits ofEVLP,startingitseffectsinthedonorhospital, reducing inthiswaythecoldischemictime(Fig 1).2 According to theINSPIREtrial,theOCSLunghasbeenmostlyusedfor ideal organpreservation,andveryfewcasesofmarginallung reconditioning havebeenreported.3–5 To date,noclinicalcaseshavebeenreportedonclinicaland functional lungperformancewithtissueevaluation.The authors presenttheir first caseofmarginallungreconditioning with theOCSLungsystem.
2016
Ex vivo lung perfusion
EVLP
Ischemia-reperfusion injury
lung transplantation
Marginal donor
Cardiology and Cardiovascular Medicine
Anesthesiology and Pain Medicine
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/78390
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact